This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is true for within-subjects designs? A) There must be at least three ... (Read 21 times)

sheilaspns

  • Hero Member
  • *****
  • Posts: 567
Which of the following is true for within-subjects designs?
 
  A) There must be at least three conditions manipulated.
  B) Participants are all randomly assigned to conditions.
  C) Each participant serves as his or her own control.
  D) They require more participants than do between-subjects designs.

Question 2

The advantage of a within-subjects design is that
 
  A) the F-ratio is reduced.
  B) randomized participant assignment is maximized.
  C) it requires fewer dependent measures.
  D) it equates participant in conditions prior to experimental manipulation.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bassamabas

  • Sr. Member
  • ****
  • Posts: 294
Answer to Question 1

Answer: C

Answer to Question 2

Answer: D




sheilaspns

  • Member
  • Posts: 567
Reply 2 on: Aug 4, 2018
Wow, this really help


Alyson.hiatt@yahoo.com

  • Member
  • Posts: 354
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

Normal urine is sterile. It contains fluids, salts, and waste products. It is free of bacteria, viruses, and fungi.

Did you know?

Approximately 500,000 babies are born each year in the United States to teenage mothers.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library